C07K 1 - General processes for the preparation of peptides

Patents for C07K 1 - General processes for the preparation of peptides (51,718)
12/1999
12/21/1999	US6005075 Purification; use in antitumor and/or antiviral treatment
12/21/1999	US6004931 Method for inhibiting growth hormone action
12/21/1999	US6004768 Crosslinked enzyme or antibody crystals may be used in an assay, diagnostic kit or biosensor for detecting an analyte, in an extracorporeal device for altering a component of a fluid
12/21/1999	US6004757 Determining an amino acid sequence motif for a phosphorylation site of a protein kinase
12/21/1999	CA2183160C Displacement chromatography of proteins using low molecular weight displacers
12/21/1999	CA2143510C Method for the isolation and purification of vitamin k-dependent proteins
12/21/1999	CA2092708C Cationic charge modified microporous membranes
12/21/1999	CA1340858C Recombinant and native group b eimeria tenella immunogens useful as coccidiosis vaccines
12/21/1999	CA1340857C Synthetic plasmid transformant, feline interferon gene and method for producing feline interferon
12/21/1999	CA1340855C Neurite-promoting factor and process for the manufacture thereof
12/21/1999	CA1340853C Purification of recombinant interleukin-2
12/16/1999	WO1999064574A1 Method to prepare c-terminal modified peptides
12/16/1999	WO1999064495A1 FUNCTIONALISED POLYMERS OF α-AMINO ACIDS AND THE METHOD OF PREPARATION THEREOF
12/16/1999	WO1999064462A1 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
12/16/1999	WO1999064441A1 Method for preparing virus-safe pharmaceutical compositions
12/16/1999	WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999	WO1999064038A1 Novel analgesic agents
12/16/1999	WO1999064036A1 Novel therapeutic agents for macromolecular structures
12/16/1999	WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064032A1 Combinatorial synthesis of multibinding libraries
12/16/1999	WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	WO1999063999A1 H1-histamine receptor antagonists
12/16/1999	WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999	WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999	WO1999055899A9 Methods for transducing fusion molecules
12/16/1999	WO1999055718A3 Solution phase biopolymer synthesis
12/16/1999	CA2321273A1 Novel analgesic agents
12/16/1999	CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999	CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	CA2319651A1 H1-histamine receptor antagonists
12/16/1999	CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999	CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	CA2319085A1 Novel therapeutic agents for macromolecular structures
12/16/1999	CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999	CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2318547A1 Combinatorial synthesis of multibinding libraries
12/16/1999	CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999	CA2318055A1 .beta.2-adrenergic receptor agonists
12/15/1999	EP0963435A1 Methods for production of proteins
12/15/1999	EP0963246A1 Automated chemical synthesis device
12/15/1999	EP0758349A4 Surface-modifying endgroups for biomedical polymers
12/15/1999	EP0567567B1 A RECEPTOR TYROSINE KINASE TARGET PROTEIN cDNA CLONING METHOD AND hGRB PROTEINS
12/15/1999	CN1238782A Colostrinin and uses thereof
12/14/1999	US6001993 Testing the phoshorous bearing monomers for chemical suitability, reacting selected monomers with solid support or growing chain, mixing all supports together, dividing mixture, repeating coupling steps
12/14/1999	US6001974 Method of separating albumin from serum by ion-exchange chromatography with membrane adsorbers
12/14/1999	US6001966 Reacting n-terminal protected amino acid with peptide starting material forming a peptide product, partitioning from unreacted material and reagents based on presence of n-terminal blocking/anchoring group
12/14/1999	US6001961 Cyclic adhesion inhibitors
12/14/1999	US6001800 Atomizing into hot air an aqueous solution of recombitant human erythropoietin to evapororate sprayed particles to dryness, separating
12/14/1999	US6001598 Two new human DnaJ-like proteins
12/14/1999	US6001364 Comprising a baseplate structure having a plurality of oxime bonds, wherein each oxime bond links a specifically active molecule to the baseplate; for inducing an immune response in an animal
12/14/1999	CA2089161C Separation of proteins and dyes
12/14/1999	CA2084186C Purification of human interleukin-4 secreted from a escherichia coli mutant
12/14/1999	CA1340852C Process for purifying primate gm-csf protein
12/09/1999	WO1999062939A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
12/09/1999	WO1999062937A1 Purification of antibodies
12/09/1999	WO1999062936A1 Separation of protein monomers from aggregates by use of ion-exchange chromatography
12/09/1999	WO1999062935A1 Reaction products between carboxylic acid and amino acid or amino acid condensate and process for producing the same
12/09/1999	WO1999062933A2 Rationally designed peptides, production and use thereof
12/09/1999	WO1999062930A2 Protein sequencing using tandem mass spectroscopy
12/09/1999	WO1999049292A9 Reagents and methods for protein microsequencing
12/09/1999	DE19826442A1 Rational designte Peptide, ihre Herstellung und ihre Verwendung Rational designed peptides, their preparation and their use
12/09/1999	CA2333655A1 Purification of antibodies
12/08/1999	EP0962465A1 Methods of cyclisation of penta- and hexapeptides
12/08/1999	EP0961831A1 Human endokine alpha
12/08/1999	EP0961652A1 Laminated assembly for active bioelectronic devices
12/07/1999	US5998588 Interactive molecular conjugates
12/07/1999	US5998580 Providing an amino acid including a photolabile molecule and incorporating the amino acid into a peptide during synthesis, wherein incorporation of the amino acid into the peptide produces a photosensitive peptide
12/07/1999	US5998577 Method for determining mimotopes
12/07/1999	US5998213 C-terminal sequencing of peptides which may include proline
12/07/1999	US5998169 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
12/07/1999	US5998157 Contacting sample with antibody and binding partner in presence of acylated protein aggregate
12/07/1999	US5998155 Stable composition of immobilized protein having affinity for biotin
12/07/1999	US5997933 N-(3,3-dimethylbutyl)-L-aspartyl-D-α-aminoalkanoic acid N-(S)-1-phenyl-1-alkanamide useful as a sweetening agent
12/07/1999	CA1340841C Cecropin-like polypeptides with activity against gram-positive and gram-negative bacteria
12/07/1999	CA1340838C Coccidiosis vacine
12/02/1999	WO1999061913A2 Improvements in or relating to diagnosis and treatment of bacterial infections
12/02/1999	WO1999061653A2 Light-mediated regional analysis of biologic material
12/02/1999	WO1999061649A1 Method for recovering soluble protein
12/02/1999	WO1999061583A2 Carbohydrate-based scaffold compounds, combinatorial libraries and methods for their construction
12/02/1999	WO1999061475A1 Method for separating and/or isolating plasma proteins by annularchromatography
12/02/1999	WO1999061474A1 Purified human activin and process for producing the same
12/02/1999	WO1999061473A1 Method for purification of borrelia lipoprotein ospa

1 ... 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 ... 518